NL192870C - Anti-hypertensief oraal farmaceutisch preparaat. - Google Patents

Anti-hypertensief oraal farmaceutisch preparaat. Download PDF

Info

Publication number
NL192870C
NL192870C NL7812164A NL7812164A NL192870C NL 192870 C NL192870 C NL 192870C NL 7812164 A NL7812164 A NL 7812164A NL 7812164 A NL7812164 A NL 7812164A NL 192870 C NL192870 C NL 192870C
Authority
NL
Netherlands
Prior art keywords
day
hydrochlorothiazide
blood pressure
hours
administered
Prior art date
Application number
NL7812164A
Other languages
English (en)
Dutch (nl)
Other versions
NL192870B (nl
NL7812164A (nl
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25343256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192870(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of NL7812164A publication Critical patent/NL7812164A/xx
Publication of NL192870B publication Critical patent/NL192870B/xx
Application granted granted Critical
Publication of NL192870C publication Critical patent/NL192870C/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7812164A 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat. NL192870C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86442877A 1977-12-27 1977-12-27
US86442877 1977-12-27

Publications (3)

Publication Number Publication Date
NL7812164A NL7812164A (nl) 1979-06-29
NL192870B NL192870B (nl) 1997-12-01
NL192870C true NL192870C (nl) 1998-04-02

Family

ID=25343256

Family Applications (2)

Application Number Title Priority Date Filing Date
NL7812164A NL192870C (nl) 1977-12-27 1978-12-14 Anti-hypertensief oraal farmaceutisch preparaat.
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL980017C NL980017I1 (nl) 1977-12-27 1998-04-24 Anti-hypertensief oraal farmaceutisch preparaat.

Country Status (30)

Country Link
JP (1) JPS54110333A (de)
AR (1) AR230378A1 (de)
AU (1) AU526239B2 (de)
BE (1) BE873092A (de)
CA (1) CA1120400A (de)
CH (1) CH642542A5 (de)
DE (1) DE2854316C3 (de)
DK (1) DK578778A (de)
EG (1) EG14178A (de)
FI (1) FI783991A (de)
FR (1) FR2413089A1 (de)
GB (1) GB2010675B (de)
GR (1) GR72951B (de)
HK (1) HK45483A (de)
HU (1) HU178747B (de)
IE (1) IE48306B1 (de)
IL (1) IL56281A (de)
IT (1) IT1202811B (de)
KE (1) KE3235A (de)
LU (1) LU80709A1 (de)
MY (2) MY8300240A (de)
NL (2) NL192870C (de)
NO (1) NO784357L (de)
NZ (1) NZ189159A (de)
PH (1) PH22111A (de)
PL (1) PL212188A1 (de)
PT (1) PT68983A (de)
SE (1) SE445173B (de)
SG (1) SG41482G (de)
ZA (1) ZA786948B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829950B2 (ja) * 1978-10-05 1983-06-25 ウェルファイド株式会社 環状イミノカルボン酸誘導体およびその塩類
US4350704A (en) 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4482725A (en) * 1980-04-03 1984-11-13 E. R. Squibb & Sons, Inc. S-Acylation products of mercaptoacyl amino acids and carboxyl group containing diuretics
US4344949A (en) 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4532342A (en) * 1981-02-20 1985-07-30 Warner-Lambert Company N-substituted amino acids as intermediates in the preparation of acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4552889A (en) * 1983-06-09 1985-11-12 Eli Lilly And Company 3-Mercaptomethyl-2-oxo-1-pyrrolidine acetic acids and use for hypertension
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis
DE3532036A1 (de) * 1985-09-09 1987-03-26 Hoechst Ag Pharmazeutische zubereitung zur behandlung des bluthochdrucks
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996024358A1 (en) * 1995-02-10 1996-08-15 G.D. Searle & Co. Use of low dose amount of spironolactone for treatment of cardiovascular disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU509899B2 (en) * 1976-02-13 1980-05-29 E.R. Squibb & Sons, Inc. Proline derivatives and related compounds

Also Published As

Publication number Publication date
PL212188A1 (de) 1980-02-11
AR230378A1 (es) 1984-04-30
AU526239B2 (en) 1982-12-23
EG14178A (en) 1984-06-30
PH22111A (en) 1988-06-01
IE48306B1 (en) 1984-12-12
PT68983A (en) 1979-01-01
NZ189159A (en) 1984-12-14
CA1120400A (en) 1982-03-23
MY102991A (en) 1993-03-31
CH642542A5 (de) 1984-04-30
GB2010675B (en) 1982-06-16
IE782413L (en) 1979-06-27
NL192870B (nl) 1997-12-01
JPS647045B2 (de) 1989-02-07
FI783991A (fi) 1979-06-28
FR2413089B1 (de) 1980-12-26
DE2854316C2 (de) 1989-08-10
DE2854316C3 (de) 1994-12-22
HK45483A (en) 1983-10-28
GR72951B (de) 1984-01-17
IL56281A0 (en) 1979-03-12
NL980017I1 (nl) 1998-07-01
LU80709A1 (de) 1979-04-13
JPS54110333A (en) 1979-08-29
HU178747B (en) 1982-06-28
MY8300240A (en) 1983-12-31
GB2010675A (en) 1979-07-04
DK578778A (da) 1979-06-28
IT7831266A0 (it) 1978-12-22
FR2413089A1 (fr) 1979-07-27
SG41482G (en) 1985-01-11
DE2854316A1 (de) 1979-07-05
SE7813277L (sv) 1979-06-28
ZA786948B (en) 1980-04-30
BE873092A (fr) 1979-06-27
AU4204178A (en) 1979-07-05
IT1202811B (it) 1989-02-09
IL56281A (en) 1983-05-15
KE3235A (en) 1982-11-05
SE445173B (sv) 1986-06-09
NL7812164A (nl) 1979-06-29
NO784357L (no) 1979-06-28

Similar Documents

Publication Publication Date Title
US4217347A (en) Method of treating hypertension and medicaments therefor
NL192870C (nl) Anti-hypertensief oraal farmaceutisch preparaat.
US4746668A (en) Method for treating retinopathy
Plänitz Comparison of moxonidine and clonidine HCl in treating patients with hypertension
Onesti et al. Pharmacodynamic effects and clinical use of alpha methyldopa in the treatment of essential hypertension∗
CZ177397A3 (en) Use of frank incense for preparing a medicament for prophylactic and therapeutic treatment of alzheimer's disease
EP0629400B1 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
WO2001056609A1 (de) Pharmazeutische zusammensetzung für die behandlung einer durch arzneimittel induzierten hyperhomocysteinämie
EP0005015B1 (de) Verwendung eines Xanthinderivats für die Herstellung eines Arzneimittels
EP2837380B1 (de) Lercanidipinhydrochlorid- und kaliumlosartan-kombinationspräparat sowie herstellungsverfahren dafür
JP2000513356A (ja) エナラプリルとロサルタンの組成物
US4225607A (en) Pharmaceutical composition containing a xanthine derivative
CN102327272A (zh) 一种全新口服固体药用组合物及其制备方法
DK165966B (da) Forbedret piroxicamholdigt anti-inflammatorisk praeparat
JPS626687B2 (de)
JP2584636B2 (ja) 胃炎治療剤
JP3024789B2 (ja) 血圧降下剤
Wiseman et al. Development of a sustained‐release aspirin tablet
JPH0251885B2 (de)
EP0576452B1 (de) Erzeugnisse, enthaltend verapamil und trandolapril
KR20010019397A (ko) 발기부전 치료용 조성물
GB2141027A (en) Diltiazem hypolipidemic compositions
JPS58140017A (ja) 心不全治療剤
JPS5852220A (ja) 血清尿酸値低下剤
RU2183117C1 (ru) Средство для нормализации артериального давления и способ лечения гипертонической болезни

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
AC1 Application for a supplementary protection certificate

Free format text: 980017, 980424

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

BC1 Further communications concerning applications for a supplementary protection certificate

Free format text: 980017

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 981214